Editorial ArticleLife Sciences
Ready-to-use iPSC-derived cells transform CRISPR-based functional genomics
Discover how bit.bio's CRISPR-Ready ioCells eliminate months of cell line development
View articleNews & Articles
25
Best match
Product NewsLife Sciences
bit.bio launches two new human cell disease models to advance discovery and development of treatments for Duchenne muscular dystrophy (DMD)
Models will be used to investigate, screen for and develop therapies for the restoration of dystrophin, the protein that is missing in DMD patients
View article